Myeloid Therapeutics is a pioneering brand that specializes in mRNA-based immunotherapies. With a focus on improving the lives of patients, they incorporate advanced cell and gene therapy methods into their therapies. By combining disciplines such as immunology, genetics, cell biology, and protein science, Myeloid Therapeutics has developed transformative full-immune engagement designs that harness the power of myeloid biology.

Their innovative in vivo engineering platform targets and activates myeloid cells within solid tumors, triggering broader anti-tumor adaptive immunity without the need for ex-vivo cell engineering. Additionally, their retrotransposon-mediated gene-insertion technology enables the delivery of larger genetic sequences into the genome. Myeloid Therapeutics' mRNA technologies also utilize myeloid cells to combat cancer cells, produce anti-tumor agents, drive anti-tumor adaptive immunity, and modify the tumor microenvironment.

In addition to their cutting-edge science, Myeloid Therapeutics values the well-being of their patients and places them at the core of their mission. As leaders in the field, they constantly strive to improve patient outcomes and contribute to the advancement of mRNA-based immunotherapy. Contact Myeloid Therapeutics today to learn more about their transformative therapies and join their mission in addressing big human health problems